机器人辅助部分膀胱切除术治疗肌层浸润性膀胱癌：当代经验。

Robotic-assisted partial cystectomy for muscle invasive bladder cancer: Contemporary experience.

机构信息

Department of Urology, Michigan State University, The Detroit Medical Center, Detroit, Michigan, USA.

Department of Urology, The University of Toledo Medical Center, Toledo, Ohio, USA.

出版信息

Int J Med Robot. 2022 Aug;18(4):e2390. doi: 10.1002/rcs.2390. Epub 2022 Mar 13.

DOI:10.1002/rcs.2390

PMID:35262267

Abstract

OBJECTIVE

To report our contemporary experience with robotic-assisted partial cystectomy (RAPC) for muscle invasive bladder cancer.

METHODS

This is a retrospective review of patients who underwent robotic-assisted partial cystectomy with us between 2013 and 2020 and provided ≥12 months of follow up.

RESULTS AND LIMITATIONS

The median operative time for our 35 patients was 190 min (Interquartile range [IQR] 155-280). Four patients developed grade 3 or higher complications (ileus, pneumonia, and urethral stricture). At 12 months follow-up, the median IPSS score was 10 (IQR 7-11), and recurrence happened in seven patients (recurrence-free survival 80%). Five of the patients who developed recurrence died because of their disease, and two other patients died of causes unrelated to their cancer.

CONCLUSIONS

We describe our technique, functional outcomes, and short-term follow up results in highly selected patients with muscle-invasive bladder cancer treated with RAPC.

摘要

目的

报告我们在机器人辅助部分膀胱切除术（RAPC）治疗肌层浸润性膀胱癌方面的当代经验。

方法

这是一项回顾性研究，纳入了 2013 年至 2020 年间在我们中心接受机器人辅助部分膀胱切除术且随访时间≥12 个月的患者。

结果和局限性

35 例患者的中位手术时间为 190 分钟（四分位距 [IQR] 155-280）。4 例患者发生 3 级或更高级别的并发症（肠梗阻、肺炎和尿道狭窄）。12 个月随访时，中位国际前列腺症状评分（IPSS）为 10（IQR 7-11），7 例患者复发（无复发生存率 80%）。复发的 5 例患者因疾病死亡，另外 2 例患者因与癌症无关的原因死亡。